Table 1.
Description of the study population
| Characteristics | All (n = 764) |
|---|---|
| Age (years) | |
| Mean ± SD | 52.9 ± 11.8 |
| < 45 | 176 (23.0%) |
| 45–59 | 321 (42.0%) |
| ≥ 60 | 267 (35.0%) |
| HPV status | |
| Unknown or not performed | 40 (5.2%) |
| Negative | 109 (14.3%) |
| HPV16/18 | 162 (21.2%) |
| Non-16/18 HR-HPV | 453 (59.3%) |
| Cytology results | |
| Unknown or not performed | 26 (3.4%) |
| NILM | 535 (70.0%) |
| LSIL/ASCUS/AGUS | 176 (23.0%) |
| HSIL+/ASC-H | 27 (3.6%) |
| Colposcopic findings | |
| Normal | 558 (73.0%) |
| Low-grade lesion | 139 (18.2%) |
| High-grade lesion | 43 (5.6%) |
| Suspicious of cancer | 24 (3.2%) |
| Histology results | |
| <CIN2 | 680 (89.0%) |
| Normal/ cervicitis | 527 (69.0%) |
| CIN1 | 153 (20.0%) |
| CIN2+ | 84 (11.0%) |
| CIN2/CIN3 | 62 (8.1%) |
| SqCC | 18 (2.4%) |
| AC | 4 (0.5%) |
| Colposcopist | |
|
Junior Senior Indication for colposcopy |
525 (68.7%) 239 (31.3%) |
|
Abnormal clinical symptoms Abnormal vaginal bleeding Abnormal vaginal discharge Post-coital bleeding Unusual appearance of the cervix Abnormal screening results |
91 (11.9%) 31 (4.1%) 19 (2.5%) 25 (3.3%) 16 (2.1%) 673 (88.1%) |
NILM, negative for intraepithelial lesion or malignancy; LSIL, low-grade squamous intraepithelial lesion; ASCUS, atypical squamous cells of undetermined significance; AGUS, atypical glandular cells of undetermined significance; ASC-H, atypical squamous cells-cannot exclude HSIL; HSIL, high-grade squamous intraepithelial lesion; CIN, cervical intraepithelial neoplasia; CIN2+, cervical intraepithelial neoplasia grade 2 or worse; CIN2, cervical intraepithelial neoplasia grade 2; CIN3, cervical intraepithelial neoplasia grade 3; SD, standard deviation; SqCC, squamous cell carcinoma; AC, adenocarcinoma